151. Drug resistance mutations in drug-naive HIV type 1 subtype C-infected individuals from rural Malawi.
- Author
-
Bansode V, Drebert ZJ, Travers SA, Banda E, Molesworth A, Crampin A, Ngwira B, French N, Glynn JR, and McCormack GP
- Subjects
- HIV Protease genetics, HIV Reverse Transcriptase genetics, HIV-1 isolation & purification, Humans, Malawi, Molecular Sequence Data, Phylogeny, Rural Population, Sequence Analysis, DNA, Anti-HIV Agents pharmacology, Drug Resistance, Viral, HIV Infections virology, HIV-1 drug effects, HIV-1 genetics, Mutation, Missense
- Abstract
In this preliminary study we show that in 2008, 3 years after antiretroviral therapy was introduced into the Karonga District, Malawi, a greater than expected number of drug-naive individuals have been infected with HIV-1 subtype C virus harboring major and minor drug resistance mutations (DRMs). From a sample size of 40 reverse transcriptase (RT) consensus sequences from drug-naive individuals we found five showing NRTI and four showing NNRTI mutations with one individual showing both. From 29 protease consensus sequences, again from drug-naive individuals, we found evidence of minor DRMs in three. Additional major and minor DRMs were found in clonal sequences from a number of individuals that were not present in the original consensus sequences. This clearly illustrates the importance of sequencing multiple HIV-1 variants from individuals to fully assess drug resistance.
- Published
- 2011
- Full Text
- View/download PDF